Testicular function after radiotherapy for rectal cancer-a review

Journal of Sexual Medicine

Volumn 8, Issue 11, 2011, Pages 3220-3226

  Buchli, Christian ^a   Martling, Anna ^a   Arver, Stefan ^b   Holm, Torbjörn ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Radiotherapy; Rectal cancer; Rectal cancer treatment and sexual dysfunction; Testicular function; Testicular radiation dose; Testosterone

Indexed keywords

TESTOSTERONE;

BRACHYTHERAPY; CANCER RADIOTHERAPY; ERECTILE DYSFUNCTION; EXTERNAL BEAM RADIOTHERAPY; GONAD; HUMAN; ORGASM; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION DOSE; RADIATION EXPOSURE; RECTUM CANCER; REVIEW; RISK FACTOR; SEXUAL FUNCTION; SEXUAL SATISFACTION; SPERMATOGENESIS; TESTIS; TESTIS FUNCTION; TESTOSTERONE BLOOD LEVEL;

EID: 80255124820     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2011.02455.x     Document Type: Article

References (32)

1. Marijnen CA, van de Velde CJ, Putter H, van den Brink M, Maas CP, Martijn H, Rutten HJ, Wiggers T, Kranenbarg EK, Leer JW, Stiggelbout AM. Impact of short-term preoperative radiotherapy on health-related quality of life and sexual functioning in primary rectal cancer: Report of a multicenter randomized trial. J Clin Oncol 2005;23:1847-58.
2. Cedermark B, Johansson H, Rutqvist LE, Wilking N. The Stockholm I trial of preoperative short term radiotherapy in operable rectal carcinoma. A prospective randomized trial. Stockholm Colorectal Cancer Study Group. Cancer 1995;75:2269-75.
3. Martling A, Holm T, Johansson H, Rutqvist LE, Cedermark B. The Stockholm II trial on preoperative radiotherapy in rectal carcinoma: Long-term follow-up of a population-based study. Cancer 2001;92:896-902.
4. Maas CP, Moriya Y, Steup WH, Klein Kranenbarg E, van de Velde CJ. A prospective study on radical and nerve-preserving surgery for rectal cancer in the Netherlands. Eur J Surg Oncol 2000;26:751-7.
5. Lange MM, Marijnen CA, Maas CP, Putter H, Rutten HJ, Stiggelbout AM, Meershoek-Klein Kranenbarg E, van de Velde CJ. Risk factors for sexual dysfunction after rectal cancer treatment. Eur J Cancer 2009;45:1578-88.
6. Hendren SK, O'Connor BI, Liu M, Asano T, Cohen Z, Swallow CJ, Macrae HM, Gryfe R, McLeod RS. Prevalence of male and female sexual dysfunction is high following surgery for rectal cancer. Ann Surg 2005;242:212-23.
7. Howell SJ, Shalet SM. Effect of cancer therapy on pituitary-testicular axis. Int J Androl 2002;25:269-76.
8. Moher D, Liberati A, Tetzlaff J, Altman DG. Reprint-Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. Phys Ther 2009;89:873-80.
9. Budgell GJ, Cowan RA, Hounsell AR. Prediction of scattered dose to the testes in abdominopelvic radiotherapy. Clin Oncol (R Coll Radiol) 2001;13:120-5.
10. Dueland S, Guren MG, Olsen DR, Poulsen JP, Magne Tveit K. Radiation therapy induced changes in male sex hormone levels in rectal cancer patients. Radiother Oncol 2003;68:249-53.
11. Piroth MD, Hensley F, Wannenmacher M, Zierhut D. Male gonadal dose in adjuvant 3-d-pelvic irradiation after anterior resection of rectal cancer. Influence to fertility. Strahlenther Onkol 2003;179:754-9.
12. Hermann RM, Henkel K, Christiansen H, Vorwerk H, Hille A, Hess CF, Schmidberger H. Testicular dose and hormonal changes after radiotherapy of rectal cancer. Radiother Oncol 2005;75:83-8.
13. Mazonakis M, Damilakis J, Varveris H, Gourtsouiannis N. Radiation dose to testes and risk of infertility from radiotherapy for rectal cancer. Oncol Rep 2006;15:729-33.
14. Vorwerk H, Hermann RM, Christiansen H, Liersch T, Hess CF, Weiss E. A special device (double-hole belly board) and optimal radiation technique to reduce testicular radiation exposure in radiotherapy of rectal cancer. Radiother Oncol 2007;84:320-7.
15. Bruheim K, Svartberg J, Carlsen E, Dueland S, Haug E, Skovlund E, Tveit KM, Guren MG. Radiotherapy for rectal cancer is associated with reduced serum testosterone and increased FSH and LH. Int J Radiat Oncol Biol Phys 2008;70:722-7.
16. Yau I, Vuong T, Garant A, Ducruet T, Doran P, Faria S, Liberman S, Richard C, Letellier F, Charlebois P, Loungnarath R, Stein B, Devic S. Risk of hypogonadism from scatter radiation during pelvic radiation in male patients with rectal cancer. Int J Radiat Oncol Biol Phys 2009;74:1481-6.
17. Yoon FH, Perera F, Fisher B, Stitt L. Alterations in hormone levels after adjuvant chemoradiation in male rectal cancer patients. Int J Radiat Oncol Biol Phys 2009;74:1186-90.
18. Bruheim K, Guren MG, Dahl AA, Skovlund E, Balteskard L, Carlsen E, Fossa SD, Tveit KM. Sexual function in males after radiotherapy for rectal cancer. Int J Radiat Oncol Biol Phys 2010;76:1012-7.
19. Nazmy MS, El-Taher MM, Attalla EM, El-Hosiny HA, Lotayef MM. Shielding for scattered radiation to the testis during pelvic radiotherapy: Is it worth? J Egypt Natl Canc Inst 2007;19:127-32.
20. Rowley MJ, Leach DR, Warner GA, Heller CG. Effect of graded doses of ionizing radiation on the human testis. Radiat Res 1974;59:665-78.
21. Howell SJ, Shalet SM. Spermatogenesis after cancer treatment: Damage and recovery. J Natl Cancer Inst Monogr 2005;34:12-7.
22. Kinsella TJ, Trivette G, Rowland J, Sorace R, Miller R, Fraass B, Steinberg SM, Glatstein E, Sherins RJ. Long-term follow-up of testicular function following radiation therapy for early-stage Hodgkin's disease. J Clin Oncol 1989;7:718-24.
23. Centola GM, Keller JW, Henzler M, Rubin P. Effect of low-dose testicular irradiation on sperm count and fertility in patients with testicular seminoma. J Androl 1994;15:608-13.
24. Hahn EW, Feingold SM, Nisce L. Aspermia and recovery of spermatogenesis in cancer patients following incidental gonadal irradiation during treatment: A progress report. Radiology 1976;119:223-5.
25. Shapiro E, Kinsella TJ, Makuch RW, Fraass BA, Glatstein E, Rosenberg SA, Sherins RJ. Effects of fractionated irradiation of endocrine aspects of testicular function. J Clin Oncol 1985;3:1232-9.
26. Zagars GK, Pollack A. Serum testosterone levels after external beam radiation for clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 1997;39:85-9.
27. Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerdloff RS, Montori VM. Testosterone therapy in men with androgen deficiency syndromes: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2010;95:2536-59.
28. Zitzmann M, Faber S, Nieschlag E. Association of specific symptoms and metabolic risks with serum testosterone in older men. J Clin Endocrinol Metab 2006;91:4335-43.
29. Arver S, Lehtihet M. Current guidelines for the diagnosis of testosterone deficiency. Front Horm Res 2009;37:5-20.
30. Corona G, Lee DM, Forti G, O'Connor DB, Maggi M, O'Neill TW, Pendleton N, Bartfai G, Boonen S, Casanueva FF, Finn JD, Giwercman A, Han TS, Huhtaniemi IT, Kula K, Lean ME, Punab M, Silman AJ, Vanderschueren D, Wu FC. Age-related changes in general and sexual health in middle-aged and older men: Results from the European Male Ageing Study (EMAS). J Sex Med 2009;7:1362-80.
31. Wu FC, Tajar A, Beynon JM, Pye SR, Silman AJ, Finn JD, O'Neill TW, Bartfai G, Casanueva FF, Forti G, Giwercman A, Han TS, Kula K, Lean ME, Pendleton N, Punab M, Boonen S, Vanderschueren D, Labrie F, Huhtaniemi IT. Identification of late-onset hypogonadism in middle-aged and elderly men. N Engl J Med 2010;363:123-35.
32. Zugor V, Miskovic I, Lausen B, Matzel K, Hohenberger W, Schreiber M, Labanaris AP, Neuhuber W, Witt J, Schott GE. Sexual dysfunction after rectal surgery: A retrospective study of men without disease recurrence. J Sex Med 2010;7:3199-205.